This blockade led to reduced expression of IL-19-regulated genes such as TGF-β, Matrix Metalloproteinase-1 (MMP-1), CXCR4, and Cyclin B (CCNB1), highlighting the therapeutic potential of IL-19 inhibition in esophageal cancer [38]. Here, TGFB1 is linked to esophageal cancer.